Osteoporosis Risk Tests Highlight Spine and Heel Measures
The article explains osteoporosis as a systemic bone disease with common fractures in the spine hip and wrist. It notes tests for risk assessment include spine X-rays CT scans and heel hip or wrist measurements with costs ranging from 35 to 400 dollars and cites University of California San Francisco led studies showing spine or extremity measurements predict fracture risk equally.
MENTIONED IN THIS ARTICLE
University of Iowa
Cedar Rapids
University of California
San Francisco
Floyd
Heel bone density tested to predict fracture risk
NASA developed heel measurement in the 1960s for space crews. A Hawaii Osteoporosis Center study found heel bone density best predicts fractures over a decade, offering a low cost safe test to identify high risk individuals for lifestyle and therapy adjustments.
MENTIONED IN THIS ARTICLE
NASA
Hawaii
Hormone Therapy Recommended to Combat Epidemic Effects
Evanson notes estrogen and progesterone combination therapy as the best option to avoid tumor risks while preserving or increasing bone density. The discussion highlights estrogen therapy's bone benefits and potential dangers.
University of Iowa joins national trial for osteoporosis drug Alendronate
Dr. James Turner notes about 6,000 women in 11 centers participate in the FDA study. At Iowa, 500 women in the Fracture Intervention Trial aged 55 to 79 are postmenopausal and receive bone density tests. The trial follows vertebral fracture status for three to four years with calcium and vitamin D supplementation and varying treatments to slow or modify bone loss.
MENTIONED IN THIS ARTICLE
University of Iowa
Food and Drug Administration
James Turner
College of Medicine
F.I.T
U of I
Turner
New England Journal of Medicine
Woman with Lupus Avoids Hormones Faces Osteoporosis Risk
Birgerson of Cedar Rapids learned she had osteoporosis risk after stress fractures in her pelvic area led to a bone density test two years ago. Despite lupus and prednisone use, she declined estrogen replacement, citing heart concerns, until a foot fracture revealed the condition's impact on daily life.
MENTIONED IN THIS ARTICLE
Birgerson
Cedar Rapids
Rockwell International
Evaluating alternative cancer treatments for patients
In a column by Pat Meier, an oncology nurse, the piece urges logical evaluation of alternative cancer therapies. It cites Carl Sagan's Baloney Detection guide, outlines testability and scientific study, and warns of false hope. Martha’s case illustrates risks of unproven methods and the value of standard therapy.
MENTIONED IN THIS ARTICLE
Pat Meier
Cancer Control Consultants
Shirley Ruedy
Martha
Carl Sagan
Sagan
National Cancer Institute
Also Mentioned on This Page
John Floyd C.R
Health & Science
Gazette
L.W. Ward
Shally Garin
Women's Center
Mercy Medical Center
Evanson
U of
Iowa
University of Aukland
New Zealand
By Pat Meier
Cancer Update
the Gazette
P.O. Box
Spring Home & Garden
Gardening Council